Suppr超能文献

连续性肾脏替代治疗开始时机与脓毒症相关性急性肾损伤患者预后的关系

[Relationship between the timing of initiation of continuous renal replacement therapy and the prognosis of patients with sepsis-associated acute kidney injury].

作者信息

Wu Xiangwei, Ye Jihui, Sun Min, Wang Zhiyu, Chen Qiang, Zhu Jianhua

机构信息

Department of Critical Care Medicine, Ningbo First Hospital, Ningbo 315010, Zhejiang, China. Corresponding author: Zhu Jianhua, Email:

出版信息

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Nov;32(11):1352-1355. doi: 10.3760/cma.j.cn121430-20200304-00206.

Abstract

OBJECTIVE

To investigate the relationship between the timing of initiation of continuous renal replacement therapy (CRRT) and the prognosis of patients with sepsis associated-acute kidney injury (SA-AKI).

METHODS

The clinical data of SA-AKI patients undergoing CRRT in intensive care unit (ICU) of Ningbo First Hospital from January 2017 to November 2019 were retrospectively analyzed. According to the guidelines for Kidney Disease: Improving Global Outcomes (KDIGO), patients with AKI who started CRRT in stage 1 or 2 were included in the early treatment group, and those started CRRT in stage 3 were included in the late treatment group. The general clinical data, length of ICU stay, total length of hospital stay, 28-day and 90-day mortality, CRRT duration, 28-day and 90-day renal replacement therapy (RRT) disengagement rate, 28-day and 90-day RRT dependence rate in the survival patients were compared between the two groups. Kaplan-Meier survival analysis was performed to assess the 90-day cumulative survival rate of patients with SA-AKI between two groups.

RESULTS

A total of 244 SA-AKI patients were enrolled in this study, including 71 patients in the early treatment group and 173 patients in the late treatment group. There were no significant differences in age, gender composition, acute physiology and chronic health evaluation II (APACHE II), proportion of surgical patients, infection site and anticoagulation program between the two groups. The CRRT duration in the early group was significantly shorter than that in the late group [hours: 26.0 (12.0, 49.0) vs. 41.0 (20.8, 87.0), P < 0.01], but there were no significant differences in the length of ICU stay [days: 9.0 (4.0, 15.0) vs. 10.0 (4.5, 18.0)], total length of hospital stay [days: 17.0 (10.0, 30.0) vs. 18.0 (10.0, 32.0)], 28-day mortality (45.1% vs. 48.0%), 90-day mortality (46.4% vs. 51.4%), 28-day RRT disengagement rate (49.3% vs. 45.1%) and 90-day RRT disengagement rate (52.1% vs. 47.4%) between the early treatment group and late treatment group (all P > 0.05). There were also no significant differences in 28-day RRT dependence rate [10.3% (4/39) vs. 13.3% (12/90)] and 90-day RRT dependence rate [2.6% (1/38) vs. 2.4% (2/84)] between early treatment group and late treatment group (both P > 0.05). Kaplan-Meier survival analysis suggested that there was no significant difference in the 90-day cumulative survival rate between two groups (Log-Rank test: χ = 0.791, P = 0.374).

CONCLUSIONS

Early initiation of CRRT treatment in SA-AKI patients can reduce the duration of CRRT, but has no effect on length of ICU stay, total length of hospital stay, renal function recovery and mortality. At present, the optimal timing for initiation of CRRT in patients with SA-AKI remains unknown.

摘要

目的

探讨持续肾脏替代治疗(CRRT)开始时机与脓毒症相关性急性肾损伤(SA-AKI)患者预后的关系。

方法

回顾性分析2017年1月至2019年11月在宁波市第一医院重症监护病房(ICU)接受CRRT治疗的SA-AKI患者的临床资料。根据改善全球肾脏病预后组织(KDIGO)指南,将在1期或2期开始CRRT的急性肾损伤患者纳入早期治疗组,在3期开始CRRT的患者纳入晚期治疗组。比较两组患者的一般临床资料、ICU住院时间、总住院时间、28天和90天死亡率、CRRT持续时间、28天和90天肾脏替代治疗(RRT)撤机率、存活患者的28天和90天RRT依赖率。采用Kaplan-Meier生存分析评估两组SA-AKI患者的90天累积生存率。

结果

本研究共纳入244例SA-AKI患者,其中早期治疗组71例,晚期治疗组173例。两组患者在年龄、性别构成、急性生理与慢性健康状况评分系统II(APACHE II)、手术患者比例、感染部位及抗凝方案等方面差异无统计学意义。早期组的CRRT持续时间明显短于晚期组[小时:26.0(12.0,49.0) vs. 41.0(20.8,87.0),P < 0.01],但早期治疗组与晚期治疗组在ICU住院时间[天:9.0(4.0,15.0) vs. 10.0(4.5,18.0)]、总住院时间[天:17.0(10.0,30.0) vs. 18.0(10.0,32.0)]、28天死亡率(45.1% vs. 48.0%)、90天死亡率(46.4% vs. 51.4%)、28天RRT撤机率(49.3% vs. 45.1%)和90天RRT撤机率(52.1% vs. 47.4%)方面差异均无统计学意义(均P > 0.05)。早期治疗组与晚期治疗组在28天RRT依赖率[10.3%(4/39) vs. 13.3%(12/90)]和90天RRT依赖率[2.6%(1/38) vs. 2.4%(2/84)]方面差异也无统计学意义(均P > 0.05)。Kaplan-Meier生存分析表明,两组患者的90天累积生存率差异无统计学意义(Log-Rank检验:χ = 0.791,P = 0.374)。

结论

SA-AKI患者早期开始CRRT治疗可缩短CRRT持续时间,但对ICU住院时间、总住院时间、肾功能恢复及死亡率无影响。目前,SA-AKI患者开始CRRT的最佳时机仍不清楚。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验